CN103361198B - 川芎消炎复合香皂 - Google Patents
川芎消炎复合香皂 Download PDFInfo
- Publication number
- CN103361198B CN103361198B CN201310193059.2A CN201310193059A CN103361198B CN 103361198 B CN103361198 B CN 103361198B CN 201310193059 A CN201310193059 A CN 201310193059A CN 103361198 B CN103361198 B CN 103361198B
- Authority
- CN
- China
- Prior art keywords
- ligusticum wallichii
- parts
- sodium
- soap
- perfumed soap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000344 soap Substances 0.000 title claims abstract description 45
- 241000112528 Ligusticum striatum Species 0.000 title claims abstract description 19
- 206010061218 Inflammation Diseases 0.000 title abstract description 5
- 230000003467 diminishing effect Effects 0.000 title abstract 4
- 230000004054 inflammatory process Effects 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000002994 raw material Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 claims abstract description 6
- 239000011734 sodium Substances 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- 239000002131 composite material Substances 0.000 claims description 9
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 8
- -1 hydroxyethyl diamine Chemical class 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 239000003352 sequestering agent Substances 0.000 claims description 7
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 6
- PDIZYYQQWUOPPK-UHFFFAOYSA-N acetic acid;2-(methylamino)acetic acid Chemical compound CC(O)=O.CC(O)=O.CNCC(O)=O PDIZYYQQWUOPPK-UHFFFAOYSA-N 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 claims description 6
- 229940092705 beclomethasone Drugs 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000003760 tallow Substances 0.000 claims description 6
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 6
- 235000019864 coconut oil Nutrition 0.000 claims description 5
- 239000003240 coconut oil Substances 0.000 claims description 5
- 239000006260 foam Substances 0.000 abstract description 4
- KJDVLQDNIBGVMR-UHFFFAOYSA-L disodium;3-[2-aminoethyl-[2-(2-carboxylatoethoxy)ethyl]amino]propanoate Chemical compound [Na+].[Na+].[O-]C(=O)CCN(CCN)CCOCCC([O-])=O KJDVLQDNIBGVMR-UHFFFAOYSA-L 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 abstract 1
- 229940079857 disodium cocoamphodipropionate Drugs 0.000 abstract 1
- 229940080279 sodium cocoate Drugs 0.000 abstract 1
- 229940045870 sodium palmitate Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 239000003814 drug Substances 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004898 kneading Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229940120146 EDTMP Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- OHOTVSOGTVKXEL-WJXVXWFNSA-K trisodium;(2s)-2-[bis(carboxylatomethyl)amino]propanoate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)[C@H](C)N(CC([O-])=O)CC([O-])=O OHOTVSOGTVKXEL-WJXVXWFNSA-K 0.000 description 2
- BPSYZMLXRKCSJY-UHFFFAOYSA-N 1,3,2-dioxaphosphepan-2-ium 2-oxide Chemical compound O=[P+]1OCCCCO1 BPSYZMLXRKCSJY-UHFFFAOYSA-N 0.000 description 1
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- QILXPCHTWXAUHE-UHFFFAOYSA-N [Na].NCCN Chemical compound [Na].NCCN QILXPCHTWXAUHE-UHFFFAOYSA-N 0.000 description 1
- OQRDSLOUOFIGSC-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na].NCCNCCN Chemical compound [Na].[Na].[Na].[Na].[Na].NCCNCCN OQRDSLOUOFIGSC-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- RWIGWWBLTJLKMK-UHFFFAOYSA-N diethoxyphosphorylmethanol Chemical compound CCOP(=O)(CO)OCC RWIGWWBLTJLKMK-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HPEUEJRPDGMIMY-IFQPEPLCSA-N molybdopterin Chemical compound O([C@H]1N2)[C@H](COP(O)(O)=O)C(S)=C(S)[C@@H]1NC1=C2N=C(N)NC1=O HPEUEJRPDGMIMY-IFQPEPLCSA-N 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 208000011309 nasal bleeding Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- WHNXAQZPEBNFBC-UHFFFAOYSA-K trisodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].OCCN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O WHNXAQZPEBNFBC-UHFFFAOYSA-K 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Abstract
Description
实施例1 | 实施例2 | 实施例3 | 实施例4 | 对比例1 |
川芎提取物 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
椰油酸钠 | 20 | 20 | 20 | 20 | 20 |
棕榈酸钠 | 60 | 60 | 60 | 60 | 60 |
椰油酰两性基二丙酸二钠 | 4 | 4 | 4 | 4 | / |
氢化牛脂基胺氧化物 | 4 | 4 | 4 | 4 | / |
α-月桂基烷基甜菜碱 | / | / | / | / | 8 |
甲基甘氨酸二乙酸三钠盐 | / | 1 | / | 0.5 | / |
羟乙基二胺四乙酸三钠盐 | / | / | 1 | 0.5 | / |
水 | 20 | 20 | 20 | 20 | 20 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310193059.2A CN103361198B (zh) | 2013-05-22 | 2013-05-22 | 川芎消炎复合香皂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310193059.2A CN103361198B (zh) | 2013-05-22 | 2013-05-22 | 川芎消炎复合香皂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103361198A CN103361198A (zh) | 2013-10-23 |
CN103361198B true CN103361198B (zh) | 2015-01-07 |
Family
ID=49363468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310193059.2A Active CN103361198B (zh) | 2013-05-22 | 2013-05-22 | 川芎消炎复合香皂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103361198B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286723A (zh) * | 1997-10-23 | 2001-03-07 | 宝洁公司 | 含多取代蛋白酶变体的清洗组合物 |
CN1670153A (zh) * | 2005-04-16 | 2005-09-21 | 王浩贵 | 川芎洗涤制品 |
CN101357109A (zh) * | 2006-12-18 | 2009-02-04 | 程宇镳 | 一种日化用品组合物 |
CN101455783A (zh) * | 2008-12-05 | 2009-06-17 | 包头市红卫日用化工有限公司 | 风湿止痛皂及其制备方法 |
CN102363740A (zh) * | 2010-12-10 | 2012-02-29 | 江南大学 | 低刺激性和高发泡性的香皂配方 |
CN102391919A (zh) * | 2011-02-14 | 2012-03-28 | 许扬 | 一种祛痘、防止皮肤过敏的中药香皂 |
-
2013
- 2013-05-22 CN CN201310193059.2A patent/CN103361198B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286723A (zh) * | 1997-10-23 | 2001-03-07 | 宝洁公司 | 含多取代蛋白酶变体的清洗组合物 |
CN1670153A (zh) * | 2005-04-16 | 2005-09-21 | 王浩贵 | 川芎洗涤制品 |
CN101357109A (zh) * | 2006-12-18 | 2009-02-04 | 程宇镳 | 一种日化用品组合物 |
CN101455783A (zh) * | 2008-12-05 | 2009-06-17 | 包头市红卫日用化工有限公司 | 风湿止痛皂及其制备方法 |
CN102363740A (zh) * | 2010-12-10 | 2012-02-29 | 江南大学 | 低刺激性和高发泡性的香皂配方 |
CN102391919A (zh) * | 2011-02-14 | 2012-03-28 | 许扬 | 一种祛痘、防止皮肤过敏的中药香皂 |
Also Published As
Publication number | Publication date |
---|---|
CN103361198A (zh) | 2013-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101125893B1 (ko) | 한방 화장비누 조성물 | |
CN111821243A (zh) | 一种用于面部的苦参祛痘控油洁面泡泡及其制备方法 | |
CN103194340B (zh) | 黄柏抗菌复合香皂 | |
CN107913228A (zh) | 含生姜的无硅油保健洗发水及其制备工艺 | |
CN103194342B (zh) | 桔梗美白复合香皂 | |
CN103666886B (zh) | 三七低刺激护肤香皂 | |
CN103361198B (zh) | 川芎消炎复合香皂 | |
CN103666884B (zh) | 地榆抗菌复合香皂 | |
CN103361211B (zh) | 薄荷清凉复合香皂 | |
CN103361209B (zh) | 蛇床子消炎复合香皂 | |
CN103666885B (zh) | 红景天低刺激护肤香皂 | |
CN105349282A (zh) | 一种多功能天然洗护液 | |
CN103194341B (zh) | 黄芩低刺激护肤香皂 | |
CN105902437A (zh) | 具有美容效果的洁面盐及制备方法 | |
CN103361210B (zh) | 地黄抑油复合香皂 | |
CN103361199B (zh) | 泽泻除体臭复合香皂 | |
CN103666888B (zh) | 蒲公英低刺激护肤香皂 | |
CN103695215B (zh) | 甘草低刺激护肤香皂 | |
CN103361212B (zh) | 夏枯草活肤复合香皂 | |
CN105687049A (zh) | 可有效去除面部暗疮的洗浴盐及制备方法 | |
CN103666887B (zh) | 芦荟低刺激护肤香皂 | |
CN105456134A (zh) | 具有保健功效的洗发盐及制备方法 | |
CN103361213A (zh) | 天冬美白复合香皂 | |
CN106580753A (zh) | 一种肉桂沐浴露及其制备方法 | |
CN107929201A (zh) | 一种防脱发的洗发液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Ren Yulong Inventor after: Li Xiaolei Inventor after: Ying Shi Inventor before: Huang Meirong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG MEIRONG TO: REN YULONG LI XIAOLEI YING SHI |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181217 Address after: 201111 E2128 first, 5500 Yuanjiang Road, Minhang District, Shanghai. Patentee after: Shanghai Yanzi Chemical Technology Co., Ltd. Address before: 201604 219, room 2, Lane 1000, Tower Road, Shek Hu Town, Songjiang District, Shanghai Patentee before: Shanghai Bafang Fine Chemical Engineering Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190920 Address after: 233010 Incubation Workshop, 414 Changle Road, Yuhui District, Bengbu City, Anhui Province Patentee after: Bengbu Xingshi Intellectual Property Operations Co., Ltd. Address before: 201111 Shanghai city Minhang District Yuanjiang Road No. 5500 building first room E2128 Patentee before: Shanghai Yanzi Chemical Technology Co., Ltd. |